Healthcare Sales & Marketing Network News: Elan

Searching News Database: Elan

HSMN NewsFeed - 8 Nov 2021
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 1 Dec 2020
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
Biopharmaceutical Personnel

HSMN NewsFeed - 9 Nov 2020
DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer
Biopharmaceutical Drug Delivery Personnel

HSMN NewsFeed - 21 Apr 2020
IDEAYA Biosciences Announces Addition of Julie Patel as Vice President, Human Resources, Enhancing its Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 May 2019
Rani Therapeutics Hires First CFO
Devices Drug Delivery Personnel

HSMN NewsFeed - 9 May 2019
MiMedx Appoints Timothy R. Wright as Chief Executive Officer
Devices Wound Care Personnel

HSMN NewsFeed - 22 Apr 2019
Neurelis Announces Completion of Senior Management Team Buildout to Support the Anticipated Commercial Launch of VALTOCO(TM)
Biopharmaceuticals Drug Delivery Neurology Personnel

HSMN NewsFeed - 1 Apr 2019
Audentes Therapeutics Appoints Legal and Corporate Communications Executives; Promotes Thomas P. Soloway to Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Nov 2018
Sutro Appoints Industry Veteran Shalini Sharp to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 9 Aug 2018
Perrigo Announces Plan To Separate Prescription Pharmaceuticals Business
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 7 Jun 2018
Egalet Appoints Industry Veteran John Varian to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Aug 2016
Flamel Technologies Launches Akovaz(TM)
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 6 Jul 2016
NeuroDerm Announces Additions to Management Team
Biopharmaceuticals Devices Neurology Personnel

HSMN NewsFeed - 7 Apr 2016
Cipher Pharmaceuticals Proposes Adding Rosemary A. Crane and Dr. Renee P. Tannenbaum To Board of Directors
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 29 Feb 2016
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 13 Apr 2015
Ultragenyx Appoints Daniel G. Welch to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Mar 2015
Novan Secures $50 Million Private Financing
Biopharmaceuticals Dermatology Venture Capital

HSMN NewsFeed - 21 Oct 2014
Viamet Announces $60 Million Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Sep 2014
Eisai Sells U.S. Rights to Zonegran(R) (zonisamide) Capsules to Concordia Pharmaceuticals Inc.
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 4 Jun 2014
Cohera Medical, Inc.(R) Appoints Richard W. Pascoe to its Board of Directors
Devices Surgery Personnel

HSMN NewsFeed - 28 Apr 2014
Coherus Biosciences Appoints Michael A. Fleming as Senior Vice President, Commercial Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Mar 2014
Pernix Therapeutics Appoints Vice President of Compliance
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Feb 2014
Pernix Attracts $65 Million Institutional Investment; Appoints Doug Drysdale as CEO; Settles Pending Legal Liabilities
Biopharmaceuticals Personnel Litigation

HSMN NewsFeed - 29 Jan 2014
XenoPort Appoints Richard Kim, M.D., as Chief Medical Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 7 Jan 2014
Velocity Pharmaceutical Development Announces Appointment of Stuart Sedlack as Senior Vice President, Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jul 2013
Perrigo Company to Acquire Elan Corporation, plc for US$8.6 Billion, Establishing Premier Global Healthcare Company
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 Jul 2013
Receptos Announces Appointment of Erle T. Mast as Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jun 2013
Royalty Pharma Statement Regarding Withdrawal of Elan Lawsuit
Biopharmaceuticals Mergers & Acquisitions Litigation

HSMN NewsFeed - 20 May 2013
Elan Announces Transactions: Decisively Transforming the Company
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 2 May 2013
A.P. Pharma Appoints New Management Team
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 15 Apr 2013
Royalty Pharma Announces Firm Offer to Acquire Elan
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 15 Feb 2013
Cohera Medical, Inc.(R) Raises $17 Million in Series D Round
Devices Surgery Venture Capital

HSMN NewsFeed - 6 Feb 2013
Biogen Idec to Acquire Full Rights and Control of TYSABRI(R) from Elan for Upfront Cash and Contingent Payments
Biopharmaceuticals Neurology Acquisitions

HSMN NewsFeed - 16 Jan 2013
Biogen Idec and Elan Submit Applications for First-Line Use of TYSABRI in Anti-JCV Antibody Negative Patients with MS
Biopharmaceuticals Neurology

HSMN NewsFeed - 15 Jan 2013
CorMedix Signs Sales and Marketing Agreement with MKM Co-Pharma, Bolsters Commercial Management Team to Ready Neutrolin(R) Catheter Lock Solution for European Market
Biopharmaceuticals Devices Distribution

HSMN NewsFeed - 4 Jan 2013
Inotek Pharmaceuticals Appoints David R. King as Executive Chairman
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 20 Sep 2012
Elan Announces the Appointment of Hans Peter Hasler as Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2012
VIVUS Announced Expansion of Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Mar 2012
BioElectronics Announces New Distribution Agreements for China, the Middle East and Other Global Opportunities
Devices Distribution

HSMN NewsFeed - 22 Feb 2012
Integrated Diagnostics(R) Secures $10 Million Third Tranche of Series A Financing
Diagnostics Venture Capital

HSMN NewsFeed - 20 Jan 2012
Quest Diagnostics STRATIFY JCV(TM) First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients
Diagnostics Neurology Personalized Medicine FDA

HSMN NewsFeed - 6 Dec 2011
Amneal Announces Corporate Business Development Team
Biopharmaceuticals Generics Personnel

HSMN NewsFeed - 15 Sep 2011
Elan Announces Board of Director Changes
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 15 Sep 2011
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jun 2011
BG Medicine, Inc. Names Stephen R. Miller Chief Commercial Officer
Diagnostics Personnel

HSMN NewsFeed - 9 May 2011
Alkermes to Merge with Elan Drug Technologies to Create Alkermes plc
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 25 Apr 2011
A.P. Pharma Announces Financing of Up to $4.5 Million and Names CEO and COO
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Mar 2011
Lithera Announces the Appointment of George W. Mahaffey as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Dec 2010
Elan Names Robert A. Ingram Chairman-Designate
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Oct 2010
IsoRay's Revolutionary Internal Radiation Therapy for Lung Cancers is Focus of National Study
Devices Oncology

HSMN NewsFeed - 22 Sep 2010
Biogen Idec Makes Statement About U.S. FDA Approval of Gilenya
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 13 Sep 2010
AVEO Pharmaceuticals, Inc. Appoints Michael P. Bailey to the Newly Created Position of Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Aug 2010
BioElectronics Announces New FDA Market Application to Broaden Its Prescription Clearance
Devices Wound Care Surgery FDA

HSMN NewsFeed - 15 Jul 2010
Elan Corporation, plc Reaches Agreement in Principle for Settlement of Investigation of Past Zonegran Sales and Marketing Activities
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jun 2010
IsoRay and Hologic Sign Exclusive Worldwide License for Crucial Brain Cancer Treatment Device
Devices Oncology Licensing

HSMN NewsFeed - 22 Jun 2010
Aragon Surgical Announces Successful First Cases with the Lektrafuse CAIMAN in Bariatric Surgery
Devices Surgery

HSMN NewsFeed - 3 Jun 2010
Elan Corporation, plc Board Announces CEO Agreement
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Feb 2010
Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA (dalfampridine)
Biopharmaceuticals Neurology

HSMN NewsFeed - 27 Jan 2010
IsoRay Hires Vice President of Research and Development
Devices Oncology Personnel

HSMN NewsFeed - 22 Jan 2010
Acorda Therapeutics Announces FDA Approval of AMPYRA (dalfampridine) to Improve Walking in People with Multiple Sclerosis - Demonstrated by Increases in Walking Speed
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 21 Jan 2010
IsoRay Announces World's First Cesium-131 Colon Cancer Treatment at Cornell Medical Center
Devices Oncology

HSMN NewsFeed - 3 Dec 2009
IsoRay Announces Iodine Distribution Agreement with GE Subsidiary, Oncura
Devices Oncology Distribution

HSMN NewsFeed - 2 Dec 2009
Seasoned Clinical Development Expert Joins Opexa to Lead Tovaxin(R) Development in Multiple Sclerosis
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 18 Nov 2009
IsoRay Announces Distribution Agreement in Canada
Devices Oncology Distribution

HSMN NewsFeed - 13 Oct 2009
Amarin Announces Changes to Its Board and Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Sep 2009
Elan Cures Breach of Tysabri(R) Collaboration Agreement and Amends Terms of Transaction with Johnson & Johnson
Biopharmaceuticals Litigation

HSMN NewsFeed - 25 Aug 2009
Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Aug 2009
IsoRay Announces FDA Clearance Supporting Enhanced Loading and Delivery Methods for the Treatment of Lung, Head and Neck, and Other Tumors
Devices Oncology FDA

HSMN NewsFeed - 10 Jul 2009
Sciele Pharma, a Shionogi Company, Terminates Agreement to Acquire Victory Pharma, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Jul 2009
Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S.
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 28 Apr 2009
RXi Pharmaceuticals Appoints Richard Chin, M.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Mar 2009
Transcept Pharmaceuticals Appoints Joseph T. Kennedy as General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Mar 2009
Victory Pharma Announces US$45 Million Equity Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Mar 2009
Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 25 Feb 2009
Elan Announces Further Alignment of Resources as Part of On-Going Strategic Review Process
Biopharmaceuticals

HSMN NewsFeed - 9 Feb 2009
MS Patients Treated with TYSABRI Remain Free of Disease Activity for Two Years, According to Data Published in the Lancet Neurology
Biopharmaceuticals Neurology

HSMN NewsFeed - 7 Jan 2009
Sangart, Inc. Announces Key Executive Appointments and Company Restructuring
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Nov 2008
David R. King Joins Diasome Pharmaceuticals as Chairman of the Board
Biopharmaceuticals Endocrinology Drug Delivery Personnel

HSMN NewsFeed - 3 Nov 2008
CyDex Pharmaceuticals Hires Vice President, Business Development and Marketing
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Oct 2008
Cohera Medical Secures $16.1 Million in Series B Financing
Devices Venture Capital

HSMN NewsFeed - 18 Sep 2008
Dr. Lars Ekman Joins Sofinnova Ventures
Venture Capital

HSMN NewsFeed - 5 Sep 2008
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Jul 2008
Biogen Idec and Elan Celebrate Second Anniversary of TYSABRI(R) for the Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Jul 2008
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day
Biopharmaceuticals

HSMN NewsFeed - 17 Jun 2008
Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of Bapineuzumab for Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 12 Jun 2008
Industry Veteran David R. King Joins Quaker BioVentures
Venture Capital

HSMN NewsFeed - 12 Jun 2008
Indevus Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jun 2008
Neuro-Hitech, Inc. Announces Acquisition of MCR American Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Jun 2008
Affymax(R) Announces Executive Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jun 2008
Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands Operations in Canada
Biopharmaceuticals

HSMN NewsFeed - 2 Jun 2008
Acorda Therapeutics Announces Positive Data from Second Phase 3 Study of Fampridine-SR on Walking Ability in People with Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 May 2008
Biogen Idec Celebrates 30 Years of Transforming Discovery into Care
Biopharmaceuticals

HSMN NewsFeed - 19 May 2008
Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 7 May 2008
Cohera Medical, Inc. Announces Closing of Insider Round of Financing for Over $7.6 Million
Devices Wound Care Venture Capital

HSMN NewsFeed - 1 May 2008
Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 17 Apr 2008
Zogenix Completes Management Team with Cynthia Robinson, Ph.D., CDO, & Mark Thompson, VP, Sales & Managed Markets
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 15 Apr 2008
Biogen Idec and Elan Present New TYSABRI(R) Data at the 60th Annual Meeting of the American Academy of Neurology
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Apr 2008
Jazz Pharmaceuticals' LUVOX CR Is Now Available for Patients With Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
Biopharmaceuticals

HSMN NewsFeed - 25 Mar 2008
APP Pharmaceuticals Launches Cefepime Hydrochloride for Injection
Biopharmaceuticals Generics

HSMN NewsFeed - 27 Feb 2008
IsoRay Appoints New Chairman and Interim CEO and Announces Management Changes upon Incumbent Resignation
Devices Personnel

HSMN NewsFeed - 30 Jan 2008
Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 29 Jan 2008
KaloBios Strengthens Development Expertise With Additions to Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jan 2008
MicroIslet Announces the Appointments of Dr. Chris Marsh as Lead Transplant Advisor, and Dr. Ronald Goldblum as Lead Clinical Development Consultant
Regenerative Medicine Personnel

HSMN NewsFeed - 22 Jan 2008
Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
Diagnostics Licensing

HSMN NewsFeed - 14 Jan 2008
FDA Approves TYSABRI(R) for the Treatment of Moderate-to-Severe Crohn's Disease
Biopharmaceuticals FDA Gastroenterology

HSMN NewsFeed - 7 Jan 2008
Biogen Idec and Elan Provide Update on Utilization, Safety and Total Patient Exposure of TYSABRI(R) in Patients with Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Dec 2007
Amarin Announces Management Changes Including Appointment of New CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Nov 2007
Zogenix Licenses Exclusive U.S. Commercial Rights for Late Stage, Controlled-Release, Opioid Product from Elan
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Nov 2007
Barr Confirms Patent Challenge of Focalin(R) XR
Biopharmaceuticals Generics

HSMN NewsFeed - 1 Nov 2007
Dawn McGuire, M.D. Joins Acologix, Inc. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Nov 2007
New Studies Unveiled at ASTRO's 49th Annual Meeting of Radiation Oncology Specialists Support the Effectiveness of IsoRay Medical's Proxcelan(TM) for the Treatment of Prostate Cancer
Devices Oncology

HSMN NewsFeed - 31 Oct 2007
Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain
Biopharmaceuticals

HSMN NewsFeed - 29 Oct 2007
Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Oct 2007
Elan and Biogen Idec Announce That FDA Will Extend Regulatory Review Period for TYSABRI(R) for Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 15 Oct 2007
Elan Update
Biopharmaceuticals

HSMN NewsFeed - 11 Oct 2007
Biogen Idec and Elan Provide Update on Utilization and Safety of TYSABRI(R) in Patients with Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 Sep 2007
Pharmacopeia Announces Senior Additions to Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Aug 2007
IsoRay Medical, Inc., Set to Transfer Production of Proxcelan(TM) (Cesium-131) Brachytherapy Seeds to New Expanded Facilities in Richland
Devices Oncology

HSMN NewsFeed - 20 Aug 2007
TYSABRI(R) Demonstrates Significant Health-Related Quality-of-Life Improvements for Multiple Sclerosis Patients in Study Published in Annals of Neurology
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Aug 2007
Affymax(R) Names Robert F. Venteicher, Ph.D., Vice President, Technical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Aug 2007
Mylan Announces Final FDA Approval for Verapamil Hydrochloride Extended-Release Capsules (PM)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 9 Aug 2007
Leading Medical Centers Join Growing Number of Locations Offering IsoRay's Prostate Cancer Treatment Proxcelan(TM) Brachytherapy Seeds (Cesium-131)
Devices Oncology

HSMN NewsFeed - 31 Jul 2007
Joint FDA Advisory Committee Recommends Approval of TYSABRI(R) for the Treatment of Moderate to Severe Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 23 Jul 2007
TYSABRI(R) Celebrates One-Year Anniversary as a Treatment for Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 20 Jul 2007
Biotechnology Start-up Nuon Therapeutics Inc. Completes $5 Million Series A Financing and Names Management Team
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 20 Jul 2007
IsoRay Medical, Inc. Introduces Branding of Cesium-131 as Proxcelan(TM) for Use in Prostate Cancer Brachytherapy
Devices Oncology

HSMN NewsFeed - 20 Jul 2007
Scientific Abstracts on Newest Isotope Used in Brachytherapy for Prostate Cancer -- IsoRay's Proxcelan(TM) with Cesium-131
Devices Oncology

HSMN NewsFeed - 19 Jul 2007
Elan and Biogen Idec Preparing to Appeal Ruling on European Application for Natalizumab for the Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 10 Jul 2007
Victory Pharma, Inc. Doubling U.S. Sales Force
Biopharmaceuticals

HSMN NewsFeed - 18 Jun 2007
Oculus Innovative Sciences Appoints Vice President of Regulatory Affairs and Quality
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jun 2007
Seattle Genetics Adds Industry Veterans John P. McLaughlin and Daniel G. Welch to its Board of Directors and Promotes Eric Dobmeier to Chief Business Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 11 Jun 2007
Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
Biopharmaceuticals

HSMN NewsFeed - 11 Jun 2007
Archemix and Merck KGaA Sign Strategic Alliance
Biopharmaceuticals

HSMN NewsFeed - 29 May 2007
Peplin Appoints Chief Commercial Officer
Biopharmaceuticals Dermatology Oncology Personnel

HSMN NewsFeed - 29 May 2007
Elan and Biogen Idec Announce a FDA Advisory Committee Meeting to Review TYSABRI(R) for the Treatment of Crohn's Disease
Biopharmacetuicals Gastroenterology FDA

HSMN NewsFeed - 22 May 2007
Zila Appoints David R. Bethune as Chairman of Board of Directors
Diagnostics Oncology Personnel

HSMN NewsFeed - 21 May 2007
Elan and Wyeth to Initiate Phase 3 Clinical Trial of Bapineuzumab (AAB-001) in Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 3 May 2007
Data Presented at the American Academy of Neurology's Annual Meeting Provide Update on Utilization and Safety of TYSABRI(R) in Patients with Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 May 2007
Victory Pharma, Inc. Completes the Acquisition of Naprelan(R)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 10 Apr 2007
TOPIGEN Expands Executive Team With Senior Business Development and Pharmaceutical Development Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Apr 2007
Elan Announces Board of Director Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Apr 2007
YM BioSciences Strengthens Program Management of Lead Drugs
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Apr 2007
FDA Grants Fast Track Designation to Alzheimer's Disease Drug Candidate AZD-103/ELND005
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 26 Mar 2007
Victory Pharma, Inc. Sales Force Expansion Signifies Growth of Its US Commercial Operations
Biopharmaceuticals

HSMN NewsFeed - 20 Mar 2007
Timothy R. Wright Appointed President of Tyco Healthcare's Pharmaceutical Products and Imaging Solutions Units
Biopharmaceuticals Devices Personnel

HSMN NewsFeed - 8 Mar 2007
CytRx RNAi Subsidiary, RXi Pharmaceuticals, Names Vice President of Pharmaceutical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Mar 2007
Amarin Expands Neurology Pipeline With Epilepsy Product Candidate
Biopharmaceuticals Drug Delivery Neurology Licensing

HSMN NewsFeed - 21 Feb 2007
ARYx Therapeutics Appoints New Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Feb 2007
Polyanalgesic Consensus Panel Issues New Guidelines for Pain Management via Intraspinal Infusion
Biopharmaceuticals

HSMN NewsFeed - 24 Jan 2007
Point Therapeutics Announces Resignation of William Whelan from Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jan 2007
Access Pharmaceuticals Names Stephen R. Seiler as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jan 2007
Auriga Laboratories Appoints Richard K. Sampson as National Sales Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jan 2007
Hi-Tech Pharmacal Enters into Agreement with Victory Pharma, Inc. to Market and Distribute Naprelan(R)
Biopharmaceuticals Distribution

HSMN NewsFeed - 21 Dec 2006
Neurocrine Announces Organizational Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Dec 2006
Gore Announces First Use of GORE Embolic Liquid to Occlude Cerebral Arteriovenous Malformation at Oregon Health & Science University
Devices Neurosurgery Interventional

HSMN NewsFeed - 15 Dec 2006
Elan and Biogen Idec Submit Supplemental Biologics License Application to the FDA for the Approval of TYSABRI(R) as a Treatment for Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 28 Nov 2006
Artes Medical Names Diane S. Goostree President and Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 27 Nov 2006
Dr. Stephen Freedman Joins Ingenium as Executive Vice President, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Nov 2006
Anadys Pharmaceuticals Names Lawrence C. Fritz, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Nov 2006
Solstice Neurosciences Raises $85 Million in Private Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 24 Oct 2006
TYSABRI(R) Maintained Remission in Patients with Moderate-to-Severe Crohn's Disease Treated for Longer Than Two Years According to Data Presented This Week
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 19 Oct 2006
CryoCath enrolls first patient in U.S. AF trial
Devices Cardiology

HSMN NewsFeed - 6 Oct 2006
New Pharmacoeconomic Data on TYSABRI(R) Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Sep 2006
New Data Presented at ECTRIMS Congress Show TYSABRI(R) Has Sustained Effect on Relapse Rate in Multiple Sclerosis Patients Treated for up to Three Years
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Sep 2006
New Data on TYSABRI(R) Presented at ECTRIMS Congress Demonstrate Significant Improvement in Cognitive Function in Patients with Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 27 Sep 2006
Elan and Transition Therapeutics Inc. Announce Global Collaboration to Develop and Commercialize Alzheimer's Disease Drug AZD-103
Biopharmaceuticals Neurology

HSMN NewsFeed - 21 Sep 2006
EKR Therapeutics Expands Management Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Aug 2006
Zogenix, Inc. Names Founding Management Team
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 27 Jul 2006
Alba Therapeutics Hires Senior Vice President of Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jul 2006
Biogen Idec and Elan Announce Availability of TYSABRI(R) for the Treatment of Relapsing Forms of Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 10 Jul 2006
Antigenics Announces Expansion of Its License and Supply Agreement With GlaxoSmithKline Biologicals for QS-21 Stimulon(R) Adjuvant
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Jul 2006
Eisai Inc. Announces Appointment of Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2006
OXiGENE'S Board of Directors Names Experienced Biotech Executive, Richard Chin, M.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jun 2006
TYSABRI(R) Receives Approval in European Union for the Treatment of Relapsing Remitting Forms of Multiple Sclerosis
Biopharmaceuticals Regulatory Neurology

HSMN NewsFeed - 19 Jun 2006
Penwest Names Benjamin Palleiko Senior Vice President, Corporate Development and CFO
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jun 2006
BioElectronics Corporation Responds to Unauthorized E-mail/SPAM Campaign Using Its Name
Devices

HSMN NewsFeed - 6 Jun 2006
Corgentech Announces Appointment of K. Peony Yu as Vice President, Clinical Research and Michael Leong as Director, Clinical Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jun 2006
FDA Approves the Reintroduction of TYSABRI(R) for the Treatment of Relapsing Forms of Multiple Sclerosis
Biopharmaceuticals FDA Neurology

HSMN NewsFeed - 17 May 2006
Renovis Names Donald R. Joseph as Senior Vice President, Corporate Development and General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 May 2006
Somaxon Pharmaceuticals Names Matthew Onaitis Vice President of Legal Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 May 2006
Cadence Pharmaceuticals Announces Additions to Senior Management and Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 May 2006
Raven Appoints George F. Schreiner, M.D., Ph.D., Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Apr 2006
CHMP Issues Positive Opinion for TYSABRI(R) as a Treatment for Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 13 Apr 2006
ArQule Announces Management and Board Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Apr 2006
New Data on TYSABRI(R) Demonstrate Significant Effects on Health-Related Quality of Life Measures in Patients with Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 3 Apr 2006
Artes Medical Names Diane Goostree President and Chief Operating Officer
Devices Dermatology Personnel

HSMN NewsFeed - 29 Mar 2006
Biogen Idec and Elan Announce Re-Initiation of TYSABRI(R) Clinical Trial Dosing in Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Mar 2006
Threshold Announces Management Additions
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Mar 2006
Biogen Idec and Elan Announce That FDA Will Extend Regulatory Review Period for the Reintroduction of TYSABRI(R) for Multiple Sclerosis
Biopharmaceuticals FDA Neurology

HSMN NewsFeed - 20 Mar 2006
Elan Closes Sale of Rights to Prialt In Europe to Eisai
Biopharmaceuticals

HSMN NewsFeed - 8 Mar 2006
FDA Advisory Committee Unanimously Recommends Reintroduction of TYSABRI(R) for the Treatment of Relapsing Forms of Multiple Sclerosis
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 1 Mar 2006
TYSABRI(R) Two-Year Phase III Multiple Sclerosis Clinical Trial Results and Safety Evaluation Published in New England Journal of Medicine
Biopharmaceuticals Neurology

HSMN NewsFeed - 23 Jan 2006
Biogen Idec and Elan Announce Notification of FDA Advisory Committee Meeting to Review TYSABRI(R) for the Treatment of Multiple Sclerosis
Biopharmaceuticals FDA Neurology

HSMN NewsFeed - 10 Jan 2006
Elan and EntreMed Execute License Agreement for Proprietary NanoCrystal(R) Technology
Biopharmaceuticals Licensing Oncology Drug Delivery

Return to NewsFeed

Additional items found! 218

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 218 additional stories matching:
Elan
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.